Navigation Links
Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
Date:1/31/2013

Life Sciences Inc., which grew to over $2 billion in revenue and was subsequently spun off as two NYSE companies.

Earlier in his career Mr. Thurman was with Rorer Pharmaceuticals Inc., where he led its successful acquisition of Revlon Healthcare and subsequent merger with Rhone-Poulenc. He was President of both Rorer Pharmaceuticals and Rhone-Poulenc Rorer Pharmaceuticals. During his tenure, the company grew in revenue to over $3 billion and posted the highest total return to shareholders in the pharmaceutical industry. Mr. Thurman has an extensive background in corporate governance having served as chairman or director of numerous public, private and academic enterprises as well as completing the Wharton Director Institute. Mr. Thurman also served as a U.S. Air Force fighter pilot in Vietnam and graduated from the U.S. Air Force Air Command & Staff College. He holds a B.S in economics from Virginia Polytechnic Institute and an M.A in economics from Webster University.

"I am excited to join the Board of Arno and look forward to working closely with Arno's management team as we continue to develop the company's technologies," said Mr. Thurman. "With promising pre-clinical and clinical results to date, this is an exciting time to join the company, and I look forward to contributing to the advancement of the company at this pivotal stage."

About Arno Therapeutics

Arno Therapeutics is a clinical-stage biopharmaceutical company developing innovative products for the treatment of cancer.  Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates with unique mechanisms of action.  These compounds are in clinical or preclinical testing as potential best- or first-in-class products to treat hematologic malignancies and solid tumors.  For more information about the company, please visit www.arn
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
2. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
3. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
4. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
5. Cell Therapeutics, Inc. (CTI) Reduces Net Loss for Third Quarter and Nine Months Ended September 30, 2012 Compared to Same Periods in 2011
6. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
7. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
8. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Regulus Appoints Mark G. Foletta to its Board of Directors
11. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Depomed, ... it intends to offer, subject to market and other ... Notes due 2021 (the "Notes"). Depomed, Inc. ("Depomed") expects ... option to purchase up to an additional $34.5 million ... Co. LLC and RBC Capital Markets, LLC will act ...
(Date:9/2/2014)...  XBiotech announced today interim results from its ... US for its anti-cancer agent Xilonix™. ... being evaluated in advanced colorectal cancer patients where ... endpoint of the study is overall survival, comparing ... population provided only palliative therapy for cachexia. ...
(Date:9/2/2014)... September 2, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
Breaking Medicine Technology:Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... , , SALT LAKE CITY , ... Heart Corporation ("WorldHeart" or "Company"), a developer of mechanical circulatory ...  the Company  received a NASDAQ Staff Deficiency Letter indicating that ... This Rule requires the Company to have at least three ...
... , BOSTON , Feb 5 ... to announce the Company has signed an agreement with Expert ... Company,s ISO 13485 quality management system (QMS) initiative. Expert Resource ... Endoscopy to create a quality management system that meets the ...
Cached Medicine Technology:NASDAQ Stock Market Confirms WorldHeart's Compliance With NASDAQ Listing Rule 5605 2Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative 2
(Date:9/2/2014)... September 03, 2014 Recently, Top ... hosting companies and announced that JustHost ( http://www.justhost.com/track/seohosts ... the webmasters. , “The hosting suppliers we recommend ... their competitors on hosting features, uptime and server ... 10 Best SEO Hosting says. “We believe that ...
(Date:9/2/2014)... 02, 2014 The use of Xarelto ... is growing at a rapid pace, even as ... courts around the U.S., Bernstein Liebhard LLP reports. According ... Medicine, within a year of its 2011 launch, patients ... warfarin, a blood thinner that has been in use ...
(Date:9/2/2014)... breast cancer in California, the percentage undergoing a double ... procedure was not associated with a lower risk of ... study in the September 3 issue of JAMA ... removal of one breast was associated with a higher ... the study. , Randomized trials have demonstrated similar survival ...
(Date:9/2/2014)... The Dream2Walk Foundation along with Gas Monkey Bar and Grill ... Cord Injury Awareness Month featuring full band performances by Zane ... Automotive will be there hosting a Hot Rod, Rat Rod, ... The car show is Pre 1964 only, with a $50.00 ... There will be trophies for top 3 and best of ...
(Date:9/2/2014)... supplements did not reduce delirium in seniors who had ... Many older hospital patients experience the sudden, severe confusion ... sleep-wake cycle. A lack of the hormone melatonin may ... has been little research into whether melatonin supplements would ... average age 84, who had hip fracture surgery. About ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2
... HEIGHTS, N.J., May 2 Authentidate,Holding Corp. (Nasdaq: ... workflow,management software and web-based services, today announced the ... on Friday, May 2,2008, at the Grand Hyatt ... election of the following individuals to,serve on Authentidate,s ...
... Inc.,(Nasdaq: OSTE ) announces today that on April ... response to its notification to Nasdaq that,Robert W. Gunn, ... of,Directors, Audit and Compensation Committees, passed away unexpectedly on,April ... independent directors,serving on its Audit Committee and is not ...
... ATLANTA, May 2 Now in its 11th year ... cancer research, Georgia Power,s Run for,the Reason relay team ... and support the American Cancer Society. This year,s relay ... Georgia Power president and,CEO who passed away from cancer ...
... On the eve of the British Columbia inquiry into the ... CMAJ (Canadian Medical Association Journal) finds that in some cases, ... evidence is contrary to current views that stun guns only ... the pulses generated by stun guns are designed to incapacitate ...
... Properties, Inc.,s (NYSE: NHP ) Board of Directors declared ... that will be paid on,June 6, 2008 to shareholders of ... of Directors declared cash dividends of,$1.9375 per share on its ... be paid on June 30, 2008 to stockholders of,record on ...
... 2 Hill-Rom Holdings,Inc., (NYSE: HRC ) invites ... president and chief executive officer, Hill-Rom. He will be,speaking ... Las Vegas on,Thursday, May 15, 2008 at 9:10 a.m. ... listen to the live presentation via the internet,link at ...
Cached Medicine News:Health News:Authentidate Holding Corp. Announces Results From Annual Meeting of Stockholders 2Health News:Authentidate Holding Corp. Announces Results From Annual Meeting of Stockholders 3Health News:Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter 2Health News:Relay Team Runs to Raise Funds for the American Cancer Society 2Health News:Evidence that stun guns may stimulate the heart 2Health News:NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: